Skip to Content

Australian Investment Blog

ASX: PME 20/11/2026

Why Pro Medicus (ASX: PME) is rallying in a falling market

Pro Medicus (ASX: PME) is trading higher this morning following another significant contract win: they announced a 10-year, A$128m agreement with NYC Health + Hospitals, New York City’s public hospital system.

The deal covers PME’s full suite of medical imaging and radiology software, reinforcing its position as a leading global provider of imaging technology.

Importantly, the contract incorporates a transaction-based pricing model, providing potential upside beyond the headline value as imaging volumes grow.

  • The announcement is another endorsement of PME’s technology and its ability to secure large, long-term contracts with major US healthcare providers.

Today’s strength is particularly encouraging given PME’s volatile year, with the stock still ~30% below its December 2025 high.  The shares suffered a sharp de-rating following February’s half-year result, while the subsequent recovery has partly reflected improving sentiment towards healthcare stocks, but today’s move is firmly around PME.

MM remains long and bullish on PME.

chart
image description
Pro Medicus Ltd (PME)
image description

Relevant suggested news and content from the site

Back to top